$PRKR
PARKERVISION INC Stock $prkr

$prkr Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000143774923014563 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$0.00	$25.00M
YoY Change
Cost Of Revenue	$63.00K	$43.00K	$3.000K
YoY Change	2000.0%	1333.33%
Gross Profit	-$63.00K	$24.96M	-$3.000K
YoY Change	2000.0%	-832000.0%
Gross Profit Margin		99.83%
Selling, General & Admin	$1.125M	$12.09M	$1.933M
YoY Change	-31.9%	525.19%	-15.22%
% of Gross Profit		48.42%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$65.00K	$66.00K	$83.00K
YoY Change	-18.75%	-20.48%	-14.43%
% of Gross Profit		0.26%
Operating Expenses	$1.125M	$12.09M	$1.933M
YoY Change	-31.9%	525.19%	-15.22%
Operating Profit	-$1.188M	$12.87M	-$1.936M
YoY Change	-28.22%	-764.88%	-15.09%
Interest Expense	$107.0K	$106.0K	$62.00K
YoY Change	-343.18%	70.97%	67.57%
% of Operating Profit		0.82%
Other Income/Expense, Net	$2.621M	$243.0K	$2.268M
YoY Change	-197.11%	-89.29%	-1312.83%
Pretax Income	$1.433M	$13.12M	$332.0K
YoY Change	-132.58%	3850.3%	-113.46%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income	0.0%	0.0%	0.0%
Net Earnings	$1.433M	$13.12M	$332.0K
YoY Change	-132.58%	3850.3%	-113.46%
Net Earnings / Revenue		52.46%
Basic Earnings Per Share	$0.02	$0.16	$0.00
Diluted Earnings Per Share	$0.01	$0.11	$0.00
COMMON SHARES
Basic Shares Outstanding	85.18M	84.52M	77.55M
Diluted Shares Outstanding	120.1M	121.7M	106.9M

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.200M	$135.0K	$198.0K
YoY Change	396.45%	-31.82%	-91.19%
Cash & Equivalents	$4.200M	$135.0K	$200.0K
Short-Term Investments
Other Short-Term Assets	$37.00K	$24.00K	$26.00K
YoY Change	-90.41%	-7.69%	100.0%
Inventory
Prepaid Expenses	$96.00K	$226.0K	$463.0K
Receivables
Other Receivables
Total Short-Term Assets	$4.333M	$14.31M	$687.0K
YoY Change	251.7%	1982.97%	-76.65%
LONG-TERM ASSETS
Property, Plant & Equipment		$3.000K	$7.000K
YoY Change		-57.14%	-74.07%
Goodwill
YoY Change
Intangibles	$1.191M	$1.252M	$1.696M
YoY Change		-26.18%	-18.34%
Long-Term Investments
YoY Change
Other Assets	$6.000K	$4.000K	$17.00K
YoY Change	-70.0%	-76.47%	41.67%
Total Long-Term Assets	$1.197M	$1.259M	$1.720M
YoY Change	-24.62%	-26.8%	-19.1%
TOTAL ASSETS
Total Short-Term Assets	$4.333M	$14.31M	$687.0K
Total Long-Term Assets	$1.197M	$1.259M	$1.720M
Total Assets	$5.530M	$15.57M	$2.407M
YoY Change	96.1%	546.82%	-52.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$785.0K	$810.0K	$944.0K
YoY Change	-14.58%	-14.19%	11.19%
Accrued Expenses	$578.0K	$580.0K	$703.0K
YoY Change	-11.21%	-17.5%	-22.58%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.751M	$1.505M	$94.00K
YoY Change	166.51%	1501.06%	-6.93%
Total Short-Term Liabilities	$3.114M	$2.895M	$1.741M
YoY Change	39.83%	66.28%	-10.63%
LONG-TERM LIABILITIES
Long-Term Debt	$10.88M	$10.65M	$8.004M
YoY Change	19.14%	33.03%	-15.99%
Other Long-Term Liabilities	$26.75M	$38.90M	$36.22M
YoY Change	-30.74%	7.42%	7.52%
Total Long-Term Liabilities	$37.62M	$49.55M	$44.22M
YoY Change	-21.2%	12.06%	2.34%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.114M	$2.895M	$1.741M
Total Long-Term Liabilities	$37.62M	$49.55M	$44.22M
Total Liabilities	$40.73M	$52.45M	$45.96M
YoY Change	-18.48%	14.11%	1.78%
SHAREHOLDERS EQUITY
Retained Earnings	-$428.7M	-$430.1M	-$433.1M
YoY Change		-0.69%	2.25%
Common Stock	$855.0K	$845.0K	$389.5M
YoY Change		-99.78%	1.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$35.20M	-$36.88M	-$43.55M
YoY Change
Total Liabilities & Shareholders Equity	$5.530M	$15.57M	$2.407M
YoY Change	96.1%	546.82%	-52.51%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$1.433M	$13.12M	$332.0K
YoY Change	-132.58%	3850.3%	-113.46%
Depreciation, Depletion And Amortization	$65.00K	$66.00K	$83.00K
YoY Change	-18.75%	-20.48%	-14.43%
Cash From Operating Activities	-$888.0K	$13.20M	-$900.0K
YoY Change	20.49%	-1566.67%	-81.96%
INVESTING ACTIVITIES
Capital Expenditures	$1.000K	$0.00	$0.00
YoY Change	-125.0%		-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.000K	$0.00	$0.00
YoY Change	-75.0%		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$42.00K	$24.00K
YoY Change		75.0%
Cash From Financing Activities	-8.971M	$797.0K	40.00K
YoY Change	-745.86%	1892.5%	-99.29%
NET CHANGE
Cash From Operating Activities	-888.0K	$13.20M	-900.0K
Cash From Investing Activities	-1.000K	$0.00	0.000
Cash From Financing Activities	-8.971M	$797.0K	40.00K
Net Change In Cash	-9.860M	$13.95M	-832.0K
YoY Change	-1621.6%	-1776.8%	-234.19%
FREE CASH FLOW
Cash From Operating Activities	-$888.0K	$13.20M	-$900.0K
Capital Expenditures	$1.000K	$0.00	$0.00
Free Cash Flow	-$889.0K	$13.20M	-$900.0K
YoY Change	21.28%	-1566.67%	-81.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	84523000
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	84523000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81246000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81246000
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-22904
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	59-2971472
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4446-1A Hendricks Avenue, Suite 354
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Jacksonville
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32207
CY2023Q1	dei	City Area Code CityAreaCode	904
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	732-6100
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	85176496
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	135000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	109000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	13925000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	226000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	244000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	24000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	30000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	14310000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	383000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1252000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1359000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5000	usd
CY2023Q1	us-gaap	Assets Assets	15569000	usd
CY2022Q4	us-gaap	Assets Assets	1751000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	810000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	901000	usd
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	47000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	23000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	29000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	79000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	501000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	486000	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	130000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	139000	usd
CY2023Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1375000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	625000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2895000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2257000	usd
CY2023Q1	us-gaap	Secured Long Term Debt SecuredLongTermDebt	38903000	usd
CY2022Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	40708000	usd
CY2023Q1	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	6545000	usd
CY2022Q4	us-gaap	Unsecured Long Term Debt UnsecuredLongTermDebt	5089000	usd
CY2023Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	3663000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	3913000	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	440000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	473000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	49551000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	50183000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	52446000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	52440000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	845000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	812000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	392388000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	391724000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-430110000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-443225000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-36877000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-50689000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15569000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1751000	usd
CY2023Q1	us-gaap	Revenues Revenues	25000000	usd
CY2022Q1	us-gaap	Revenues Revenues	0	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	43000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	3000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	24957000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	-3000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12085000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1933000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	12085000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1933000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	0	usd
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	28000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	106000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	62000	usd
CY2023Q1	prkr	Gain Loss Contingent Payment Obligation GainLossContingentPaymentObligation	349000	usd
CY2022Q1	prkr	Gain Loss Contingent Payment Obligation GainLossContingentPaymentObligation	2302000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	243000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2268000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	13115000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	332000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	109000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13115000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	332000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	83968000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77553000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	121696000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106472000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-50689000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-44777000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-36877000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-43553000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	13115000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	332000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	66000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	83000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	187000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	746000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-349000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2302000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-43000	usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-8000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-105000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-110000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-12000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	191000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-40000	usd
CY2023Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	39000	usd
CY2022Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-1204000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13154000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-872000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023Q1	prkr	Proceeds Payments From Issuance Of Common Stock Including Contingent Payment Rights ProceedsPaymentsFromIssuanceOfCommonStockIncludingContingentPaymentRights	135000	usd
CY2022Q1	prkr	Proceeds Payments From Issuance Of Common Stock Including Contingent Payment Rights ProceedsPaymentsFromIssuanceOfCommonStockIncludingContingentPaymentRights	-18000	usd
CY2023Q1	prkr	Proceeds From Warrant And Stock Option Exercised ProceedsFromWarrantAndStockOptionExercised	4000	usd
CY2022Q1	prkr	Proceeds From Warrant And Stock Option Exercised ProceedsFromWarrantAndStockOptionExercised	82000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	700000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	42000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	24000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	797000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	40000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13951000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-832000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1030000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14060000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	198000	usd
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"><b><em style="font: inherit;">1.</em> Description of Business</b></p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">ParkerVision, Inc. and its wholly-owned German subsidiary, ParkerVision GmbH (collectively “ParkerVision”, “we” or the “Company”), is in the business of innovating fundamental wireless hardware technologies and products.</p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">We have designed and developed proprietary radio frequency (“RF”) technologies and integrated circuits based on those technologies, and we license those technologies to others for use in wireless communication products. We have expended significant financial and other resources to research and develop our RF technologies and to obtain patent protection for those technologies in the United States of America (“U.S.”) and certain foreign jurisdictions. We believe certain patents protecting our proprietary technologies have been broadly infringed by others, and therefore the primary focus of our business plan is the enforcement of our intellectual property rights through patent licensing and infringement litigation efforts. We currently have patent enforcement actions ongoing in various U.S. district courts against mobile handset, smart television and other WiFi product providers, as well as semiconductor suppliers, for the infringement of a number of our RF patents. We have made significant investments in developing and protecting our technologies.</p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p>
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	13100000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	13200000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	100000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-430100000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	13900000	usd
CY2023Q1	prkr	Proceeds From Issuance Of Debt And Equity ProceedsFromIssuanceOfDebtAndEquity	800000	usd
CY2023Q1	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;"><b><em style="font: inherit;">3.</em> Basis of Presentation </b></p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The accompanying unaudited condensed consolidated financial statements for the period ended <em style="font: inherit;"> March 31, 2023</em> were prepared in accordance with generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form <em style="font: inherit;">10</em>-Q and Rule <em style="font: inherit;">10</em>-<em style="font: inherit;">01</em> of Regulation S-<em style="font: inherit;">X.</em> Operating results for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2023</em>, are <em style="font: inherit;">not</em> necessarily indicative of the results that <em style="font: inherit;"> may </em>be expected for the year ending <em style="font: inherit;"> December 31, 2023</em>, or future years. All normal and recurring adjustments which, in the opinion of management, are necessary for a fair statement of the consolidated financial condition and results of operations have been included.</p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The year-end condensed consolidated balance sheet data was derived from audited financial statements for the year ended <em style="font: inherit;"> December 31, 2022</em>. Certain information and disclosures normally included in the notes to the annual financial statements prepared in accordance with GAAP have been omitted from these interim condensed consolidated financial statements. These interim condensed consolidated financial statements should be read in conjunction with our latest Annual Report on Form <em style="font: inherit;">10</em>-K for the year ended <em style="font: inherit;"> December 31, 2022</em> (“<em style="font: inherit;">2022</em> Annual Report”).</p> <p style="font-family: "Times New Roman"; font-size: 11pt; font-variant: normal; margin: 0pt;"> </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt;">The condensed consolidated financial statements include the accounts of ParkerVision, Inc. and its wholly-owned German subsidiary, ParkerVision GmbH, after elimination of all intercompany transactions and accounts. </p> <p style="font-family: Times New Roman; font-size: 11pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt; text-indent: -18pt;"> </p>
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	25000000.0	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	13115000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	332000	usd
CY2023Q1	prkr	Income Attributable To The Dilutive Securities If Converted Or Exercised IncomeAttributableToTheDilutiveSecuritiesIfConvertedOrExercised	99000	usd
CY2022Q1	prkr	Income Attributable To The Dilutive Securities If Converted Or Exercised IncomeAttributableToTheDilutiveSecuritiesIfConvertedOrExercised	56000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	13214000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	388000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	83968000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	77553000
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	37728000
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	28919000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	121696000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106472000
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	24872000
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20759000
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14060000.00	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	135000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	13925000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2023Q1	prkr	Prepaid Services PrepaidServices	185000	usd
CY2022Q4	prkr	Prepaid Services PrepaidServices	202000	usd
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	24000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	25000	usd
CY2023Q1	prkr	Prepaid Licenses Software Tools And Support PrepaidLicensesSoftwareToolsAndSupport	15000	usd
CY2022Q4	prkr	Prepaid Licenses Software Tools And Support PrepaidLicensesSoftwareToolsAndSupport	15000	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	226000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	244000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14216000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14319000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12964000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12960000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1252000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1359000	usd
CY2023Q1	us-gaap	Convertible Debt ConvertibleDebt	5038000	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	4538000	usd
CY2023Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1375000	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	625000	usd
CY2023Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	3663000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	3913000	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	10300000
CY2023Q1	prkr	Class Of Warrant Or Right Weighted Average Remaining Life ClassOfWarrantOrRightWeightedAverageRemainingLife	P1Y10M24D
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	200000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	750000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	400000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y10M24D
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure

Files In Submission

Name	View Source	Status
0001437749-23-014563-index-headers.html	Edgar Link	pending
0001437749-23-014563-index.html	Edgar Link	pending
0001437749-23-014563.txt	Edgar Link	pending
0001437749-23-014563-xbrl.zip	Edgar Link	pending
ex_466859.htm	Edgar Link	pending
ex_466860.htm	Edgar Link	pending
ex_466861.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
prkr-20230331.xsd	Edgar Link	pending
prkr20230331_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
prkr-20230331_lab.xml	Edgar Link	unprocessable
prkr-20230331_pre.xml	Edgar Link	unprocessable
prkr20230331_10q_htm.xml	Edgar Link	completed
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
prkr-20230331_def.xml	Edgar Link	unprocessable
prkr-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRKR
PARKERVISION INC Stock $prkr

2023 Q2 Form 10-Q Financial Statement

#000143774923014563 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRKR PARKERVISION INC Stock $prkr

2023 Q2 Form 10-Q Financial Statement

#000143774923014563 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRKR
PARKERVISION INC Stock $prkr